相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Initial predictors of skin thickness progression in patients with diffuse cutaneous systemic sclerosis: Results from a multicentre prospective cohort in Japan
Masataka Kuwana et al.
MODERN RHEUMATOLOGY (2021)
New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Molecular basis for clinical diversity between autoantibody subsets in diffuse cutaneous systemic sclerosis
Kristina Elizabeth Neergaard Clark et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication
Pia Moinzadeh et al.
JOURNAL OF RHEUMATOLOGY (2020)
Abatacept in Early Diffuse Cutaneous Systemic Sclerosis: Results of a Phase II Investigator-Initiated, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis
Sabrina Hoa et al.
RHEUMATOLOGY (2020)
Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial
Dinesh Khanna et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Current and Future Outlook on Disease Modification and Defining Low Disease Activity in Systemic Sclerosis
Vivek Nagaraja et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities
Peter M George et al.
Lancet Respiratory Medicine (2020)
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial
Dinesh Khanna et al.
LANCET RESPIRATORY MEDICINE (2020)
Pathophysiology of systemic sclerosis: current understanding and new insights
Maurizio Cutolo et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2019)
Targeting very early systemic sclerosis: a case-based review
Konstantinos Melissaropoulos et al.
RHEUMATOLOGY INTERNATIONAL (2019)
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
Elizabeth R. Volkmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
Dinesh Khanna et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
K. M. Sullivan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Diagnosis and Management of Rheumatoid Arthritis A Review
Daniel Aletaha et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Does Systemic Sclerosis-associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression
Sabina A. Guler et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2018)
The European Scleroderma Trials and Research group (EUSTAR) task force for the development of revised activity criteria for systemic sclerosis: derivation and validation of a preliminarily revised EUSTAR activity index
Gabriele Valentini et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Update of EULAR recommendations for the treatment of systemic sclerosis
Otylia Kowal-Bielecka et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Circulating Anti-Nuclear Antibodies in Systemic Sclerosis: Utility in Diagnosis and Disease Subsetting
Masataka Kuwana
JOURNAL OF NIPPON MEDICAL SCHOOL (2017)
Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities
John Varga et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database
Elina G. Wirz et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Summed and Weighted Summary Scores for the Medsger Disease Severity Scale Compared with the Physician's Global Assessment of Disease Severity in Systemic Sclerosis
Daphna Harel et al.
JOURNAL OF RHEUMATOLOGY (2016)
The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis
Dinesh Khanna et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
Veronika K. Jaeger et al.
PLOS ONE (2016)
Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - Report from OMERACT CTD-ILD Working Group
Dinesh Khanna et al.
JOURNAL OF RHEUMATOLOGY (2015)
Systemic sclerosis
Yannick Allanore et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Prediction of worsening of skin fibrosis in patients with diffuse cutaneous systemic sclerosis using the EUSTAR database
Britta Maurer et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
What is the evidence for the presence of a therapeutic window of opportunity in rheumatoid arthritis? A systematic literature review
J. A. B. van Nies et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
2013 Classification Criteria for Systemic Sclerosis An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative
Frank van den Hoogen et al.
ARTHRITIS AND RHEUMATISM (2013)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
分享论文
